GENERAL COMMENTS
In this study, the authors systematically examined the associations between gestational diabetes mellitus (GDM) and risk of various cancers. They found that GDM is a risk factor for cancers of nasopharynx, kidney, lung and bronchus, breast, and thyroid gland. This is an interesting epidemiological study based on a large and a representative sample of pregnant women lived in Taiwan. Below are my comments.
Major comments:
(1)The association between GDM and breast cancer is still inclusive and controversial. According to the estrogen receptor status, breast cancer can be divided into ER negative and ER positive types. According to the study by Park et al (Park YM, Gestational diabetes mellitus may be associated with increased risk of breast cancer. 2017), the effect of GDM on breast cancer might differ across the types of breast tumors. Therefore, it will be helpful for the authors to run subgroup analysis based on the ER status of the breast cancer.
(2)It is also important to examine the effects of GDM on cancers by the numbers of GDM pregnancies, as previous studies showed that having GDM two or more times but not ever having GDM was associated with increased risk of breast cancer. It's possible that this phenomenon also applicable to other cancers. 
In this study, the authors report that women with gestational diabetes mellitus (GDM) is associated with developing cancers using the nationwide health insurance research database in Taiwan. Although there are some limitations, this paper is overall well written and contributes to the field. I have a few suggestions to improve the manuscript.
-The "non-exposed" or "comparison" group is appropriate rather than "control" group in the prospective cohort study setting.
-Confounders should be associated with both GDM and risk of cancers. The authors should provide a brief rationale that each of co-morbidities can be a confounder.
-Whether Cox proportional hazard assumption was satisfied or not should be mentioned.
-P12: Relative risk should be hazard ratio.
-In Table 3 , cancer outcomes with a few number of events (e.g. <10) should be discouraged to present the association results. Please leave your comments for the authors below In this study, the authors systematically examined the associations between gestational diabetes mellitus (GDM) and risk of various cancers. They found that GDM is a risk factor for cancers of nasopharynx, kidney, lung and bronchus, breast, and thyroid gland. This is an interesting epidemiological study based on a large and a representative sample of pregnant women lived in Taiwan. Below are my comments.
VERSION 1 -AUTHOR RESPONSE
Response: We would like to thank Dr. Xie for valuable comments. We made point-by-point responses as follows.
Q1. The association between GDM and breast cancer is still inclusive and controversial. According to the estrogen receptor status, breast cancer can be divided into ER negative and ER positive types. According to the study by Park et al (Park YM, Gestational diabetes mellitus may be associated with increased risk of breast cancer. 2017), the effect of GDM on breast cancer might differ across the types of breast tumors. Therefore, it will be helpful for the authors to run subgroup analysis based on the ER status of the breast cancer.
Response: It is true that previous investigations on the association between GDM and breast cancer have produced mixed results. In our study, we have observed a clear association between breast cancer and GDM. It is also true that Dr. Park has shown a differential impact of GDM on subtypes of breast cancer stratified by ER status (1). However, our study was based on NHIRD (National Health Insurance Research Database), which lacks information about ER status. This limitation has been stated in the revised manuscript. Nevertheless, we agree that it is an interesting topic to pursue in the future.
Q2. It is also important to examine the effects of GDM on cancers by the numbers of GDM pregnancies, as previous studies showed that having GDM two or more times but not ever having GDM was associated with increased risk of breast cancer. It's possible that this phenomenon also applicable to other cancers.
Response: The major aim of our study was to determine the risk of developing cancers in women with prior GDM. Indeed, Dr. Park has shown an association between multiple GDM pregnancy and increased risk of breast cancer (1). It is plausible that repeated episodes of GDM may augment the mitogenic and anti-apoptotic effects of hyperinsulinemia and contribute to carcinogenesis in susceptible tissues other than breast. However, in our protocol, we analyzed the data within the time frame between 2002 and 2012. The impact of multiple GDM pregnancy may not be appropriately addressed if other episodes of GDM occurred beyond the time frame. We agree it is an important issue to pursue. However, it needs to be addressed in the future in an appropriate investigational setting. We have stated this limitation in the session of Discussion of revised manuscript.
Q3. In the inclusion and exclusion section, the authors stated that they excluded 422,568 patients with missing data. The women with missing data accounted for about 1/3 of the whole pregnant women in NHIRD. If the missing related to GDM or cancer diagnosis, selection bias is very likely to occur. The authors should compare the characteristics between the excluded pregnant women and the pregnant women included into analysis. The results of this comparison could be added as a supplemental table to help judging the potential selection bias.
Response: We would like to apologize for the typo and the misunderstanding incurred. In our protocol, subjects were traced back 2 years before delivery to identify if there was a past history of malignancy or diabetes and assess baseline comorbidities which may confound the association between GDM and malignancy. Also in our protocol, participants had to be followed for at least 1 year after delivery. In this context, women with admission for delivery between Jan 1, 2002 and Dec 31, 2012 were further analyzed to avoid pre-existing malignancy and ensure adequate period of time in follow-up. In other words, we excluded those women who were admitted for delivery between Jan 1, 2000 and Dec 31, 2001 and those who were delivered between Jan 1, 2013 and Dec 31, 2013 (n=422,568). We have corrected our manuscript accordingly (Session of Material and Methods and Figure 1 ).
Q4. The explanation for the association between GDM and NPC is weak. If the authors want to use the EBV reactivation to explain the association between GDM and NPC, more direct evidence related about pre-diabetic chronic hyperinsulinemia or insulin resistance and EBV reactivation was needed.
From my point of view, focusing on the hyperinsulinemia related anti-apoptotic effects are more plausible. The association might be also explained by the shared environment or genetic factors?
Response: The association between GDM and NPC is a novel finding in our study. Although our explanation for the association between GDM and NPC through EBV infection remains speculative, EBV has been considered as the primary etiologic agent in the pathogenesis of NPC (2). Interestingly, other etiological factor like smoking has been shown to reactivate EBV infection and be involved in the pathogenesis of NPC (3, 4) . Indeed, the risk of NPC in GDM appears to be due to an interplay among several etiological factors including EBV infection, hyperinsulinemia, environmental factors, smoking, genetic predisposition. We agree that hyperinsulinemia may play an important role in the pathophysiological mechanisms in GDM women with NPC and other cancers as well. In fact, relevant discussion has been addressed in the session of Discussion. We also agree that shared risk factors for GDM and NPC and genetic susceptibility can be other explanations. Revisions have been made in the session of Discussion of revised manuscript.
Q5. The survival curves in Figure 2 is hard to read. Please use high resolution picture to replace Response: We have improved the resolution of Figure 2 .
Q6. Did the authors consider the potential confounding effects of primiparity or multiparity?
Response: We agree that it is interesting to look at the impact of parity. However, this issue may not be properly addressed in this study. The reasons are as follows: We analyzed the data within the time frame between 2002 and 2012. The influence of parity may not be appropriately addressed if other episodes of pregnancy occurred beyond the time frame. We have stated this limitation in the session of Discussion of revised manuscript.
